| Identification | Back Directory | [Name]
1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-1-methyl- | [CAS]
2252314-46-6 | [Synonyms]
Nedometinib
NFX-179/Nedometinib
1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 2-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-1-methyl- | [Molecular Formula]
C17H16FIN4O3 | [MOL File]
2252314-46-6.mol | [Molecular Weight]
470.24 |
| Hazard Information | Back Directory | [Uses]
Nedometinib is a tyrosine kinase inhibitor targeting to MEK1. Nedometinib has antineoplastic effect and can be used for research in dermatosis, cutaneous fibroneuroma, neurofibromatosis[1]. | [References]
[1] Kincaid, et al. Preparation of pyrrolopyridine-aniline compounds for treatment of dermal disorders. World Intellectual Property Organization, WO2018213810 A1. 2018-11-22. |
|
|